Clik here to view.
Mitsui Chemicals Acquires Hydrophobic, Anti-Reflective Coatings Maker COTECⓇ
TOKYO Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced that group company SDC Technologies, Inc. has acquired COTECⓇ GmbH. Engaged in the manufacture, sale...
View ArticleClik here to view.
三井化学收购疏水性防反射涂料生产商COTECⓇ
东京 (美国商业资讯)–三井化学株式会社（TOKYO:4183；总裁兼首席执行官：HASHIMOTO Osamu）今天宣布，该集团的子公司SDC Technologies, Inc.已收购COTECⓇ GmbH。制造、销售和研究疏水性抗反射涂料的COTECⓇ于2020年10月1日成为SDC的全资子公司。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Rajasthan Royals Implement RightEye’s Advanced Dynamic Vision Technology to...
JAIPUR, India The Rajasthan Royals (RR), an Indian Premier League foundational cricket team, has adopted RightEye’s Dynamic Vision testing technology and Dynamic Vision Trainer to improve its...
View ArticleClik here to view.
Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected for...
MUNICH Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced that LED Luks, a European manufacturer of LED luminaires, has adopted Seoul...
View ArticleClik here to view.
ソウル半導体の自然光LED「SunLike」、子供たちの学習向上と視力保護を目的とし、欧州幼稚園の照明に採用
韓国安山市 （ビジネスワイヤ） — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウル半導体」)は、ヨーロッパのLED照明器具メーカーLED Luks社が、自然光スペクトルLED...
View ArticleClik here to view.
首尔半导体自然光LED“SunLike”进驻欧洲幼儿园，帮助孩子们学习并保护眼睛
韩国安山 (美国商业资讯)–国际LED专营企业首尔半导体日前发布消息称，自然光光谱LED“SunLike”被应用于欧洲斯洛文尼亚私立幼儿园照明，以帮助孩子们提高学习能力并保护眼睛健康。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20201020005658/zh-CN/ 清晨光线、正午光线、傍晚光线的自然光光谱曲线...
View ArticleClik here to view.
Azura Ophthalmics Raises US$20 Million for Registration Studies for Treatment...
TEL AVIV, Israel & MELBOURNE, Australia Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye diseases, today...
View ArticleClik here to view.
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and...
OSAKA, Japan & DURHAM, N.C. Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive...
View ArticleClik here to view.
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and...
BEDFORD, Mass. Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions...
View ArticleClik here to view.
NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with...
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova® for the eye care market, announces the signing of an agreement...
View ArticleClik here to view.
Azura Ophthalmics to Present at the Piper Sandler 32nd Annual Virtual...
TEL AVIV, Israel & MELBOURNE, Australia Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye diseases, today...
View ArticleClik here to view.
Kubota Vision Announces Submission of Novel VAP-1 Inhibitors to the NCI...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today...
View ArticleClik here to view.
Mojo Vision and Menicon Announce Joint Development Agreement on Smart Contact...
SARATOGA, Calif. Mojo Vision, the Invisible Computing company, and Menicon, Japan’s first and largest contact lens manufacturer, today announced that both companies have entered into a joint...
View ArticleClik here to view.
Chugai’s Enspryng Approved in Taiwan as First Approved Medicine for...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Chugai, obtained an import drug license from the Taiwan Food and Drug...
View ArticleClik here to view.
Korea’s KAHF-Designated Hospitals Taking the Lead in Protecting Rights and...
SEOUL, South Korea Korea’s advanced medical technology attracts many foreigners to visit Korea for medical tourism and treatment each year. This press release features multimedia. View the full...
View ArticleClik here to view.
Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn®...
WOODSTOCK, Ga. Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications,...
View ArticleClik here to view.
Invincible Vision and ReflectionBio Join Forces Ahead of World Rare Disease...
SAN FRANCISCO & HONG KONG With more than 100,000 patients losing sight to Bietti’s Crystalline Dystrophy (BCD) worldwide, Invincible Vision and ReflectionBio® have joined forces to preserve...
View ArticleClik here to view.
武田提供Novavax和Moderna的COVID-19候选疫苗在日本的1/2期临床试验的最新信息
日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE:4502/NYSE:TAK)今天宣布，Novavax的COVID-19候选疫苗(TAK-019)在日本的1/2期免疫原性和安全性研究完成首例受试者接种。本月早些时候，武田完成了Moderna的COVID-19候选疫苗(TAK-919)在日本的1/2期免疫原性和安全性研究入组。 武田全球疫苗业务部总裁Rajeev Venkayya,...
View ArticleClik here to view.
Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited (“The ABL...
View ArticleClik here to view.
Standigm Secures $44.5 M in Pre-IPO Funding Round
SEOUL, South Korea Standigm Inc. (“Standigm”), a leading Korean Artificial Intelligence (AI) company for drug discovery, announces today that it has closed $44.5 million in a pre-IPO funding round...
View Article